Literature DB >> 3120190

Conformational effects of substituting amino acids for glutamine-61 on the central transforming region of the P21 proteins.

M R Pincus1, P W Brandt-Rauf, R P Carty, J Lubowsky, M Avitable, K D Gibson, H A Scheraga.   

Abstract

The low-energy conformations for a series of peptides based on the sequence of the ras P21 protein from position 55 to position 67 have been computed using conformational energy analysis. These sequences differed at position 61 and contained Gln, Pro, Leu, Lys, and Arg at this position. P21 proteins with Gln, Glu, or Pro at this position do not cause cell transformation at normal levels of expression; proteins with substitutions of at least 14 other amino acids at this position (Leu, Lys, and Arg having been found in tumors in place of the normally occurring Gln-61) do cause malignant transformation of cells in culture. We find that the segments of residues 55-67 from the nontransforming proteins (Gln- or Pro-61) adopt a structure that is energetically unfavorable for the same segment with Leu, Lys, or Arg at position 61. The critical feature of this structure is an alpha-helix from residues 62 to 68. Residue 61 (Gln or Pro) adopts an extended conformation. On the other hand, the segment from transforming proteins can adopt two structures, one all alpha-helical from residue 61 to residue 68 and the other a less-regular, higher-energy structure. The segments from the normal protein can adopt the all alpha-helical structure, a finding that can explain the fact that elevated intracellular levels of the normal protein also cause cell transformation. The results of the calculations suggest that specific changes in the structure of this region can account for the oncogenic effect of the proteins in which substitutions occur.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3120190      PMCID: PMC299545          DOI: 10.1073/pnas.84.23.8375

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Transient reversion of ras oncogene-induced cell transformation by antibodies specific for amino acid 12 of ras protein.

Authors:  J R Feramisco; R Clark; G Wong; N Arnheim; R Milley; F McCormick
Journal:  Nature       Date:  1985 Apr 18-24       Impact factor: 49.962

2.  Role of medium-range interactions in proteins.

Authors:  P K Ponnuswamy; P K Warme; H A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

3.  Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules.

Authors:  J B Gibbs; I S Sigal; M Poe; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

4.  Conformational analysis of the 20 naturally occurring amino acid residues using ECEPP.

Authors:  S S Zimmerman; M S Pottle; G Némethy; H A Scheraga
Journal:  Macromolecules       Date:  1977 Jan-Feb       Impact factor: 5.985

5.  Biological properties of human c-Ha-ras1 genes mutated at codon 12.

Authors:  P H Seeburg; W W Colby; D J Capon; D V Goeddel; A D Levinson
Journal:  Nature       Date:  1984 Nov 1-7       Impact factor: 49.962

6.  Analysis of the transforming potential of the human H-ras gene by random mutagenesis.

Authors:  O Fasano; T Aldrich; F Tamanoi; E Taparowsky; M Furth; M Wigler
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

7.  Mechanism of activation of a human oncogene.

Authors:  C J Tabin; S M Bradley; C I Bargmann; R A Weinberg; A G Papageorge; E M Scolnick; R Dhar; D R Lowy; E H Chang
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

8.  A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene.

Authors:  E P Reddy; R K Reynolds; E Santos; M Barbacid
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

9.  Prediction of the three-dimensional structure of the transforming region of the EJ/T24 human bladder oncogene product and its normal cellular homologue.

Authors:  M R Pincus; J van Renswoude; J B Harford; E H Chang; R P Carty; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

10.  Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein.

Authors:  D W Stacey; H F Kung
Journal:  Nature       Date:  1984 Aug 9-15       Impact factor: 49.962

View more
  11 in total

1.  Correlation of the structure of the transmembrane domain of the neu oncogene-encoded p185 protein with its function.

Authors:  P W Brandt-Rauf; S Rackovsky; M R Pincus
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Structure of the carboxyl terminus of the RAS gene-encoded P21 proteins.

Authors:  P W Brandt-Rauf; R P Carty; J Chen; M Avitable; J Lubowsky; M R Pincus
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

3.  Conformational effects of the substitution of Arg for Gly 13 in the ras oncogene-encoded P21 protein.

Authors:  P W Brandt-Rauf; R P Carty; J Carucci; M Avitable; J Lubowsky; M R Pincus
Journal:  J Protein Chem       Date:  1988-08

4.  Conformational effects of amino acid substitutions in the P-glycoprotein of the mdr 1 gene.

Authors:  P W Brandt-Rauf; G Lee; R P Carty; M R Pincus; J M Chen
Journal:  J Protein Chem       Date:  1989-08

5.  Structural implications of the substitution of Val for Met at residue 239 in the alpha chain of human platelet glycoprotein Ib.

Authors:  M R Pincus; R P Carty; J L Miller
Journal:  J Protein Chem       Date:  1994-10

6.  Comparison of the low energy conformations of an oncogenic and a non-oncogenic p21 protein, neither of which binds GTP or GDP.

Authors:  A Liwo; K D Gibson; H A Scheraga; P W Brandt-Rauf; R Monaco; M R Pincus
Journal:  J Protein Chem       Date:  1994-02

7.  Comparison of the predicted structure for the activated form of the P21 protein with the X-ray crystal structure.

Authors:  J M Chen; G Lee; P W Brandt-Rauf; R B Murphy; S Rackovsky; M R Pincus
Journal:  J Protein Chem       Date:  1990-10

Review 8.  Oncogene proteins as biomarkers in the molecular epidemiology of occupational carcinogenesis. The example of the ras oncogene-encoded p21 protein.

Authors:  P W Brandt-Rauf
Journal:  Int Arch Occup Environ Health       Date:  1991       Impact factor: 3.015

9.  Low Energy Conformations for S100 Binding Peptide from the Negative Regulatory Domain of p53.

Authors:  Robert P Carty; Bo Lin; Daniel Fridman; Matthew R Pincus
Journal:  Protein J       Date:  2018-12       Impact factor: 2.371

10.  Conformation of the metastasis-inhibiting laminin pentapeptide.

Authors:  P W Brandt-Rauf; M R Pincus; R P Carty; J Lubowsky; M Avitable; J Carucci; R B Murphy
Journal:  J Protein Chem       Date:  1989-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.